Uncategorized

On Monday, June 13th, Dr. A. Mark Fendrick, Director of the Center for Value-Based Insurance Design (V-BID), spoke at the China-US Precision Medicine Industry and Policy Forum.  The Forum is part of a larger event, titled "The Fourth Shenzhen International Low Carbon City Forum," and took place in Shenzhen, Guangdong Province, China.  Dr. Fendrick also participated in an additional roundtable event held on Sunday, June 12th. The event will bring together health economists and policy stakeholders to discuss the opportunities and challenges of using genomic science to improve the quality and efficiency of health care and public health services delivery in China and internationally.  Dr. Fendrick will discuss V-BID in the context of the Chinese health system and precision medicine. Dr. Fendrick's presentation, including the Chinese translation, can be found below.   Dr. Fendrick presenting about the key tenets of                   V-BID strategy in China. [...]

On Sunday, June 12th, Dr. A. Mark Fendrick, Director of the Center for Value-Based Insurance Design (V-BID), will speak at the Chinese Economist Society's Roundtable Discussion on precision medicine.  The roundtable discussion is part of a larger event, titled "The Fourth Shenzhen International Low Carbon City Forum," and will take place in Shenzhen, Guangdong Province, China.  Dr. Fendrick will also participate in an additional forum event held on Monday, June 13th.   The roundtable event will bring together health economists and policy stakeholders to discuss the opportunities and challenges of using genomic science to improve the quality and efficiency of health care and public health services delivery in China and internationally.  Dr. Fendrick will discuss V-BID in the context of the Chinese health system and precision medicine. Dr. Fendrick's presentation and the event agenda can be found below.     Dr. Fendrick addressing the Chinese Economic     [...]

Access to prescription drugs is a hot-button health care issue. The V-BID center proposes an innovative and dynamic benefit design - Reward the Good Soldier - that recognizes that individualized therapies are often needed to achieve desired health outcomes.